Time to Take Another Look at Alternatives
by Asset Allocation Team, GMO LLC Some investors still shudder when they consider their experience with hedge funds.…
Prepare, Don’t Predict: Building Resilient Portfolios with Private Credit
For decades, investors climbed the 60/40 ladder with confidence. Now, every step feels less steady. High inflation that refuses to budge, interest rates that won’t come down anytime soon, and the growing correlation between stocks and bonds...
Many Happy (Fundamental) Returns
by Tom Hancock, Anthony Hene and Ty Cobb, GMO LLC There aren’t many laws of investing, but our…
GMO: American Unexceptionalism
by Ben Inker and John Pease, GMO LLC Executive Summary Investors today take for granted that the S&P…
Frenzied Speculation in U.S. Stocks
How to Exploit or Protect Against It
Value: That Was Then, This is Now
by Asset Allocation Team, GMO LLC At GMO, we are valuation-sensitive investors — not reflexive “value” investors. That…
Trade: The Most Beautiful Word in the Dictionary
by Ben Inker Co-Head, Asset Allocation, and John Pease, Asset Allocation Team, GMO LLC The global trade situation…
Three Reasons we’re Overweight Japanese Equities
by Rick Friedman and John Thorndike, GMO LLC In a world of rich valuations and heightened geopolitical uncertainties,…
Rising Toxicity and the Threat to Capitalism and Life Itself
by Jeremy Grantham, GMO LLC This article represents the personal views of Jeremy Grantham and may not necessarily…
Bargain, Value Trap or Something in Between?
by Ben Inker and Anna Chetoukhin, GMO LLC Executive summary Over the last decade, U.S. large cap growth…
Bargain, Value Trap or Something in Between?
Analyzing the Also-rans in a Magnificent Bull Market for Growth by Ben Inker and Anna Chetoukhin, GMO LLC…
The Future of the Inflation Reduction Act – Rhetoric vs. Reality
by Lucas White, Portfolio Manager, Focused Equity, GMO LLC Introduction Republicans have lashed out at the Inflation Reduction…
Quality: The Real McCoy
2024 ETF Update by Kim Mayer, Research Analyst, GMO LLC Executive summary At GMO we have spent the…
GMO: Don’t Miss Out
by Catherine LeGraw, Partner, Asset Allocation Team, GMO LLC A Historic Opportunity in Deep Value Why Value Now?…
A Second Opinion Is Just What the Doctor Ordered
by Ben Inker, Head of Asset Allocation, GMO LLC A valuation-aware, dynamic approach to strategic allocation Asset Allocation…
Equity Dislocation
by Asset Allocation Team, GMO LLC Explaining Strong Returns in the Face of Value Headwinds Equity Dislocation was…
